* Date : 2021-09-30
Korean pharmaceutical companies have announced plans to conduct large-scale clinical trials for their COVID-19 vaccine candidates on human subjects across the world, bringing the country one step closer to securing a homegrown vaccine. We sit down with our panel of experts for more on the latest in Korea’s quest to develop an indigenous vaccine.
- Guests In-Studio
- LEE Hoon-sang, Professor / Yonsei University Graduate School of Public Health
- Howard LEE, Professor / Dept. of Molecular Medicine, Seoul National University
- Skype Interview
- Vorasuang DUANGCHINDA, Director / Office of Online Education, Sripatum University